Invitation to Scandion Oncology webcast and conference call November 16, 2022
Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, will publish its Q3 2022 interim report on Wednesday November 16, 2022, before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session.Access to the event can be obtained as follows: LIVE access on Wednesday November 16, 2022, at 10:00 CET Webcast: https://